Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Sparing Care Pathway for Patients Undergoing Obesity Surgery
2017-003830-97Phase 4Active
- Sponsor
- Sahlgrenska University Hospital
- Start
- Dec 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, esketamine, lidocaine and remifentanil in obesity, sponsored by Sahlgrenska University Hospital. Started Dec 2017; status: active.
02
Drugs
dexmedetomidineesketaminelidocaineremifentanil
03
Conditions
obesity
Beyond the preview
Go deeper on 2017-003830-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003830-97.